Hikma Pharmaceuticals Plc (OTCMKTS:HKMPF – Get Free Report)’s share price hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as $21.87 and last traded at $21.87, with a volume of 985 shares. The stock had previously closed at $22.09.
Hikma Pharmaceuticals Trading Down 1.0%
The company has a current ratio of 1.24, a quick ratio of 0.72 and a debt-to-equity ratio of 0.33. The company’s fifty day simple moving average is $24.80 and its 200-day simple moving average is $26.23.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.
Featured Stories
- Five stocks we like better than Hikma Pharmaceuticals
- What is an Earnings Surprise?
- Cybersecurity Market Set to Double: This ETF Offers Exposure
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Downgraded But Not Done: 3 Stocks Ready for a Market Comeback
- Trading Halts Explained
- Solana Beat BTC and ETH in Q3: These 3 Stocks Saw It Coming
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
